RioDerm-004 by Rion for Fistula: Likelihood of Approval

RioDerm-004 is under clinical development by Rion and currently in Phase I for Fistula.

Helfie AI Partners with Microsoft to Expand Access to AI-Powered Health Assessments

What You Should Know: – Helfie AI, a global mobile health platform, has announced a strategic collaboration with Microsoft to offer its cutting-edge health assessment

October 31, 2024

California floats extending health insurance subsidies to all adult immigrants

Marisol Pantoja Toribio found a lump in her breast in early January. Uninsured and living in California without legal status and without her family, the

May 3, 2024

Artificial wombs, after years in development, reach FDA review for human trials

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans. The technology is close

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.